Jacinta Holmes

Low failure to attend rates and increased clinic capacity with Telehealth: A highly effective outpatient model that should continue beyond the COVID-19 pandemic

G Tambakis, T Lee, R Shah, E Wright, W Connell, A Miller, B Demediuk, M Ryan, J Howell, E Tsoi, M Lust, C Basnayake, N Ding, C Croagh, T Hong, M Kamm, A Farrell, T Papaluca, M MacIsaac, D Iser, et al.

Journal article  |  2021  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C

Timothy Papaluca, Anne Craigie, Lucy McDonald, Amy Edwards, Michael MacIsaac, Jacinta A Holmes, Matthew Jarman, Tanya Lee, Hannah Huang, Andrew Chan, Mark Lai, Vijaya Sundararajan, Joseph S Doyle, Margaret Hellard, Mark Stoove, Jessica Howell, Paul Desmond, David Iser, Alexander J Thompson

Journal article  |  2020  |  PLOS ONE

BACKGROUND AND AIMS: Prison-based HCV treatment rates remain low due to multiple barriers, including accessing transient elastogra..

Virtually perfect? High patient satisfaction and reduced work absenteeism using a telehealth model of inflammatory bowel disease care during the coronavirus pandemic

R Shah, G Tambakis, J Holmes, W Connell, J Ding, O Niewiadomski, M Lust, A Thompson, C Basnayake, M Kamm, E Wright

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Quantitative hepatitis B surface antigen levels: A new biomarker for chronic hepatitis B infection

A Trytell, J Holmes, J Williams, J Howell, M Ryan, T Hong, B Demediuk, D Iser, T Papaluca, S Hall, K Visvanathan, P Desmond, C Croagh, S Glasgow, K New, B Whitton, A Thompson

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Silver lining of a very dark cloud: Telehealth virtually perfect in the COVID-19 era

G Tambakis, R Shah, E Wright, W Connell, A Miller, B Demediuk, M Ryan, J Howell, E Tsoi, M Lust, C Basnayake, J Ding, C Croagh, T Hong, M Kamm, A Farrell, T Papaluca, M Macisaac, D Iser, S Mahady, et al.

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A growing problem: Non-alcoholic fatty liver disease-related hepatocellular carcinoma is increasing and associated with low rates of surveillance participation and poor overall survival

E Chen, J Holmes, J Howell, M Ryan, M Macisaac, J Gough, A Thompson

Conference Proceedings  |  2020  |  JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Validation of the TREAT-B score for hepatitis B treatment eligibility in a large Asian cohort: TREAT-B improves with age

Jessica Howell, David Anderson, Stephen Bloom, John Lubel, William Kemp, James Williams, Sally Bell, Catherine Croagh, Barbara Demediuk, Paul Desmond, Sam Hall, Jacinta Holmes, Hong Thai, David Iser, Lucy Lim, Timothy Papaluca, Marno Ryan, Kumar Visvanathan, Yinzong Xiao, Caroline van Gemert, et al.

Journal article  |  2020  |  JOURNAL OF HEPATOLOGY

A prospective study of nucleot(s)ide analogue discontinuation in non-cirrhotic HBeAg-negative chronic hepatitis B patients: interim analysis at week 48 demonstrates profound reductions of HBsAg associated with ALT flare

Samuel Hall, Gareth Burns, Miriam Levy, John Lubel, Amanda Nicoll, Gail Matthews, Paul Desmond, William Sievert, Scott Bowden, Stephen Locarnini, Jacinta Holmes, Kumar Visvanathan, Alexander Thompson

Journal article  |  2020  |  Journal of Hepatology

Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.

Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Jacinta A Holmes, Meng-Hsuan Hsieh, Yi-Shan Tsai, Po-Cheng Liang, Pei-Chien Tsai, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Raymond T Chung, Ming-Lung Yu

Journal article  |  2020  |  J Hepatol

BACKGROUND & AIMS: The outcome of HBV infection, including the dynamics of HBsAg and HBV virological reactivation, among patients ..

New approaches in viraemic organ transplantation and antiviral therapies.

Jacinta A Holmes, Raymond T Chung

Journal article  |  2020  |  Nat Rev Gastroenterol Hepatol